Company intelligence / Profile preview

Superstring Capital Master Fund

New York, NY, United States

Ownership: Private
Employees: ~5
Development stage: Other

Overview

Superstring Capital Master Fund is an institutional investment fund focused on public and private equity in healthcare, biotechnology, and pharmaceuticals, with investment concentrated in mid- and small-cap companies in the life sciences sector. Their reported trading activity as of June 30, 2025, encompasses 34 equity holdings, predominantly in biopharma, biotech, and healthcare companies.

Industry: Investors

Partnerships

Participated as investor in Zenas BioPharma (alongside SR One, NEA, Norwest, etc.)

Beyond the preview

Go deeper on Superstring Capital Master Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Superstring Capital Master Fund.

Explore the full profile